AR245504A1 - Molecula de dna que codifica la proteina mas abundante en el sobrenadante del cultivo de lactococous spec. - Google Patents

Molecula de dna que codifica la proteina mas abundante en el sobrenadante del cultivo de lactococous spec.

Info

Publication number
AR245504A1
AR245504A1 AR91319296A AR31929691A AR245504A1 AR 245504 A1 AR245504 A1 AR 245504A1 AR 91319296 A AR91319296 A AR 91319296A AR 31929691 A AR31929691 A AR 31929691A AR 245504 A1 AR245504 A1 AR 245504A1
Authority
AR
Argentina
Prior art keywords
active
spec
lactis
abundant protein
lactococous
Prior art date
Application number
AR91319296A
Other languages
English (en)
Spanish (es)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Application granted granted Critical
Publication of AR245504A1 publication Critical patent/AR245504A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/853Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
AR91319296A 1990-03-22 1991-03-22 Molecula de dna que codifica la proteina mas abundante en el sobrenadante del cultivo de lactococous spec. AR245504A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909006400A GB9006400D0 (en) 1990-03-22 1990-03-22 Bacterial vectors

Publications (1)

Publication Number Publication Date
AR245504A1 true AR245504A1 (es) 1994-01-31

Family

ID=10673033

Family Applications (1)

Application Number Title Priority Date Filing Date
AR91319296A AR245504A1 (es) 1990-03-22 1991-03-22 Molecula de dna que codifica la proteina mas abundante en el sobrenadante del cultivo de lactococous spec.

Country Status (22)

Country Link
US (1) US5559007A (OSRAM)
EP (1) EP0449770B1 (OSRAM)
JP (1) JPH04211384A (OSRAM)
KR (1) KR910016930A (OSRAM)
AR (1) AR245504A1 (OSRAM)
AT (1) ATE174055T1 (OSRAM)
AU (1) AU643511B2 (OSRAM)
BR (1) BR9101137A (OSRAM)
CA (1) CA2038706A1 (OSRAM)
DE (1) DE69130544T2 (OSRAM)
DK (1) DK0449770T3 (OSRAM)
ES (1) ES2125864T3 (OSRAM)
FI (1) FI911367L (OSRAM)
GB (1) GB9006400D0 (OSRAM)
HU (1) HUT57263A (OSRAM)
IE (1) IE910948A1 (OSRAM)
MX (1) MX25027A (OSRAM)
NO (1) NO911138L (OSRAM)
NZ (1) NZ237506A (OSRAM)
PT (1) PT97081B (OSRAM)
TW (1) TW213488B (OSRAM)
ZA (1) ZA912114B (OSRAM)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286361A (en) * 1992-10-19 1994-02-15 Regents Of The University Of California Magnetically attached sputter targets
AU2149495A (en) * 1995-04-11 1996-10-30 Nederlandse Organisatie Voor Toegepast- Natuurwetenschappelijk Onderzoek Tno Method for the construction of vectors for lactic acid bacte ria like lactobacillus such that the bacteria can efficientl y express, secrete and display proteins at the surface
GB9521568D0 (en) * 1995-10-20 1995-12-20 Lynxvale Ltd Delivery of biologically active polypeptides
EP0925364B1 (en) * 1996-09-06 2002-10-23 Bioteknologisk Institut A lactic acid bacterial regulatable expression system
EP1239032A1 (en) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
US7780961B2 (en) 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
WO2004001020A2 (en) 2002-06-19 2003-12-31 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Methods and means to promote gut absorption
WO2004046346A2 (en) * 2002-11-15 2004-06-03 Vib Vzw Self-containing lactobacillus strain
RU2420569C2 (ru) 2005-11-29 2011-06-10 Актогеникс Нв Индукция толерантности к антигенам через слизистую
CN101605900B (zh) 2007-01-12 2014-04-23 阿克图杰尼斯公司 乳球菌启动子和其用途
CA3037889C (en) 2007-01-25 2022-09-13 Intrexon Actobiotics Nv Treatment of immune disease by mucosal delivery of antigens
JP5126879B2 (ja) * 2007-07-13 2013-01-23 独立行政法人海洋研究開発機構 新規dna断片およびそれを含む組換えベクター、それらによって形質転換された形質転換体、ならびにそれらの利用
WO2010034844A1 (en) 2008-09-29 2010-04-01 Actogenix N.V. Reduced colonization of microbes at the mucosa
CA2760248C (en) 2009-04-30 2019-05-28 Actogenix Nv Cryoprotectants for freeze drying of lactic acid bacteria
EP2275527A1 (en) 2009-07-17 2011-01-19 ActoGeniX NV Animal component-free culture medium for bacterial fermentation
EP2483409B1 (en) 2009-09-29 2017-03-22 Intrexon Actobiotics NV LACTOBACILLUS glyceraldehyde-3-phosphate dehydrogenase PROMOTERS AND USES THEREOF
JP2013530187A (ja) 2010-06-17 2013-07-25 ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ シークレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ 炎症性疾患を治療するための組成物及び方法。
EP3360967B1 (en) 2011-06-01 2020-09-09 Intrexon Actobiotics NV Polycistronic expression system for bacteria
RU2653757C2 (ru) 2011-09-23 2018-05-14 Интрексон Актобиотикс Н.В. Модифицированные грамположительные бактерии и их применение
JP6117212B2 (ja) 2011-09-23 2017-04-19 イントレクソン・アクトバイオテイクス・エヌブイIntrexon Actobiotics NV 改変されたグラム陽性菌及びその使用
EP3919065B9 (en) 2016-01-14 2024-01-24 Intrexon Actobiotics NV Compositions and methods for the treatment of type 1 diabetes
EP3601572A4 (en) * 2017-03-22 2021-01-06 Agency for Science, Technology and Research PROTEIN EXPRESSION CONSTRUCTION AND RELATED PROCESSES
CN116144690A (zh) * 2022-08-23 2023-05-23 江西省科学院微生物研究所(江西省流域生态研究所) 一种大肠杆菌与乳酸菌的穿梭载体pDXA及构建方法与应用
WO2025233675A1 (en) 2024-05-10 2025-11-13 Institut Pasteur Use of talosaminidase to regulate populations of archaeal methanogens in industrial, agricultural and medical settings
WO2025253171A1 (en) 2024-06-04 2025-12-11 Institut Pasteur Characterization of viruses associated with the zoonotic fish-borne oncogenic liver flukes and applications thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8400687A (nl) 1984-03-02 1985-10-01 Unilever Nv Recombinant plasmiden; recombinant plasmiden bevattende bacterien; werkwijze voor het bereiden of vervaardigen van een zuivelproduct; werkwijze voor het bereiden van een eiwit.
EP0168342B1 (de) 1984-06-14 1991-07-03 Ciba-Geigy Ag Verfahren zur Herstellung von Thrombin-Inhibitoren
NL8503316A (nl) * 1985-11-29 1987-06-16 Stichting Nl I Zuivelonderzoek Werkwijze voor het bereiden van proteinen met behulp van gastheer-organismen, in het bijzonder melkzuurbacterien, welke recombinant dna-plasmiden met een hoge replicon-aktiviteit en een hoge promotor-aktiviteit voor het betreffende proteine-coderende gen bevatten, de van dergelijke recombinant dna-plasmiden voorziene gastheerorganismen, de recombinant dna-plasmiden zelve, de replicon-aktiviteit en promotor-aktiviteit coderende dna-fragmenten, alsmede de verkregen proteinen.
EP0316677A3 (en) 1987-11-13 1990-04-25 Miles Inc. Method for cloning in lactic acid bacteria
NL9000753A (nl) * 1990-03-30 1991-10-16 Nl Zuivelonderzoek Inst Dna-fragment, ten minste coderend voor een deel van het extracellulaire eiwit met een schijnbaar molecuulgewicht van 60 kda van lactococcus lactis stammen zoals de lactococcus lactis ssp. lactis stam mg1363, combinaties hiervan met voor homologe of heterologe eiwitten coderende dna-sequenties alsmede de hiermee verkregen homologe en heterologe eiwitten.

Also Published As

Publication number Publication date
FI911367A7 (fi) 1991-09-23
EP0449770A3 (en) 1992-07-01
IE910948A1 (en) 1991-09-25
TW213488B (OSRAM) 1993-09-21
NO911138L (no) 1991-09-23
MX25027A (es) 1993-12-01
PT97081A (pt) 1991-11-29
NZ237506A (en) 1992-12-23
HU910958D0 (en) 1991-10-28
FI911367L (fi) 1991-09-23
CA2038706A1 (en) 1991-09-23
AU7355891A (en) 1991-10-03
ATE174055T1 (de) 1998-12-15
BR9101137A (pt) 1991-11-05
NO911138D0 (no) 1991-03-21
GB9006400D0 (en) 1990-05-23
ZA912114B (en) 1992-01-29
DK0449770T3 (da) 1999-06-23
DE69130544T2 (de) 1999-04-29
EP0449770B1 (en) 1998-12-02
PT97081B (pt) 1998-07-31
JPH04211384A (ja) 1992-08-03
AU643511B2 (en) 1993-11-18
DE69130544D1 (de) 1999-01-14
ES2125864T3 (es) 1999-03-16
HUT57263A (en) 1991-11-28
US5559007A (en) 1996-09-24
FI911367A0 (fi) 1991-03-20
KR910016930A (ko) 1991-11-05
EP0449770A2 (en) 1991-10-02

Similar Documents

Publication Publication Date Title
AR245504A1 (es) Molecula de dna que codifica la proteina mas abundante en el sobrenadante del cultivo de lactococous spec.
Buchan et al. Distribution and co-localization of calbindin D28k with VIP and neuropeptide Y but not somatostatin, galanin and substance P in the enteric nervous system of the rat
FI20011554A7 (fi) Polyetyleeni-proteiinikonjugaatteja
ATE29215T1 (de) Diaethylpropionpraeparate mit verzoegerter wirkung.
TR199800794T2 (xx) Sinerjistik herbisid kar���mlar�.
CO5580776A2 (es) Formulacion farmaceutica estable en solucion de oxaliplatino
CO5271726A1 (es) Composicion farmaceutica soluble en agua en un complejo ionico y el uso de la misma
ES2151599T3 (es) Acidos hidroxamicos substituidos con arilsulfonamido como inhibidores de matriz metaloproteinasas.
CY1105917T1 (el) Αναλογα ομοιου με γλυκαγονη πεπτιδιου-1
CO5300417A1 (es) Composiciones de polipeptidos toxicas para insectos antonomus, y metodos de uso
EA199800140A1 (ru) Композиции с контролируемым высвобождением пароксетина
ES507236A0 (es) Un procedimiento para preparar una composicion farmaceutica para aplicacion topica, empleada en el tratamiento del acne.
ES2146214T3 (es) Vacunas para actinobacillus pleuropneumoniae.
SHIMIZU Pathogenicity of an infections flacherie virus of the silkworm bombyx mori, obtained from sericultural farms in the suburbs of ina city
IT8020274A0 (it) Poltrona anatomica asimmetrica, particolarmente per uso odontoiatrico.
ZA928836B (en) Substituted benzimidazoles, process for their preparation as well as their use.
CO5040014A1 (es) Mezclas fungicidas
ATE283058T1 (de) Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von dysphorie
FR2433506A1 (fr) Derives de 2-acyl-6-aminomethylphenol et procede permettant leur preparation
ATE324906T1 (de) Verwendung von chimäres il6-il6r in huntingtonskrankheit
Benenstein Khirbat el-Keik (B)
IT1113373B (it) Derivati del 1,5-dimetilbiciclo(3.2.1.)-ottano,preparazione di questi composti e loro impiego come composti per profumi
ES274975Y (es) Valvula individual perfeccionada, principalmente para el campo sanitario.
Sa ‘id Tel Regev, Cemetery
Davis Kukhla